Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06493500

Efficacy of Formulated Eggshell Derived Nano-hydroxyapatite Containing Toothpaste With and Without Addition of Fluoride vs. Conventional Desensitizing Fluoride Containing Toothpaste in Management of Dentin Hypersensitivity

Efficacy of Nano-hydroxyapatite Containing Tooth Paste on Dentin Hypersensitivity of Adult Patient

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
39 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

compare the effectiveness of Eggshell derived nano-Hydroxyapatite with and without fluoride and conventional fluoride containing tooth paste versus conventional desensitizing fluoride containing tooth paste on dentinal tubule occlusion and dentin mineral deposition.

Detailed description

Recently advanced nanotechnology has taken a wide leap in improving the various measures in the treatment of hypersensitivity by its nanoparticles. Nanoparticles can easily penetrate into dentin tubules, which could act as mineralizing agents that block fluid movement within the dentin tubules when combined with various agents. Hydroxyapatite (HAp) is the major inorganic component of natural teeth and bone. Nano-sized particles of hydroxyapatite are similar to the apatite crystals of tooth enamel in morphology and crystal structure and has been studied as a biomimetic material for the reconstruction of tooth enamel suffering from mineral loss because of its unique potential for remineralization. Nano-hydroxyapatite (n-HAp) was considered a promising active ingredient used for the treatment of DH due to high biocompatibility and bioactivity. In toothpastes, HAp was included in the form of nanocrystals because they dissolve easier in this form. Crystals of n-HAp included in dental products have a dimension of 50-1000 nm, which enables them to act like fillers. These products can penetrate and block the exposed dentinal tubules which are responsible for DH

Conditions

Interventions

TypeNameDescription
DRUGEggshell derived Nano-hydroxyapatite (n-HAp) with a Fluoride containing toothpastepatients would be instructed to treat their teeth for 5 min twice a day with the provided toothpaste.
DRUGEggshell derived Nano-hydroxyapatite (n-HAp) without a Fluoride containing toothpastepatients would be instructed to treat their teeth for 5 min twice a day with the provided toothpaste.

Timeline

Start date
2024-07-01
Primary completion
2025-02-01
Completion
2025-03-01
First posted
2024-07-10
Last updated
2024-07-10

Source: ClinicalTrials.gov record NCT06493500. Inclusion in this directory is not an endorsement.